In the press

Richard Williams comments on FEML results in Investment Week

Biotech trusts top performance charts in February

Richard Williams comments on FEML’s strong record in Michael Nelson’s article:

“Emerging markets had an exceptional year, but a 92.3% NAV return against 48.2% from the index shows there was considerably more at work than a rising tide.”

Read the article here